Brief: Theriva Biologics, Sant Joan de Déu-Barcelona Children’s Hospital to Explore Combination of VCN-01 with Topoisomerase Inhibitors to Treat Cancer
02/11/2023 12:42
Nov 2 (Reuters) - Theriva Biologics Inc TOVX.A :
* THERIVA™ BIOLOGICS AND SANT JOAN DE DÉU-BARCELONA
CHILDREN’S
HOSPITAL ADVANCE STRATEGIC COLLABORATION TO EXPLORE THE
COMBINATION OF VCN-01 WITH TOPOISOMERASE INHIBITORS TO TREAT
CANCER
Source text for Eikon: ID:nGNX1QySs5
Further company coverage: TOVX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theriva Biologics
See all newsTheriva Biologics Q2 net loss narrows on lower R&D costs, expenses
Brief: Theriva™ Biologics Announces Upcoming Presentation Of Additional Data From The Virage Phase 2B Clinical Trial Of Vcn-01 In Metastatic Pancreatic Cancer At Aacr 2026 Annual Meeting
Brief: Theriva Biologics Licenses Syn-020 To Rasayana Therapeutics For Multiple Indications
Brief: Theriva Biologics Implements 32% Workforce Reduction - SEC Filing
Brief: Theriva™ Biologics Announces Presentation Of Data From Vcn-01 Retinoblastoma Phase 1 Clinical Trial At Asco 2025